Clinical Outcomes of Continuous Addition of Androgen Deprivation Therapy During Docetaxel Chemotherapy for Patients With Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

Clinical Outcomes of Continuous Addition of Androgen Deprivation Therapy During Docetaxel Chemotherapy for Patients With Castration-Resistant Prostate Cancer

Published:2017-08-31 Issue:2 Volume:15 Page:59-65
ISSN:2234-4977
Container-title:The Korean Journal of Urological Oncology
language:en
Short-container-title:Korean J Urol Oncol

Author:

Lee Dong Hoon,Kim Jung Ho,Seo Won Ik,Nam Jong Kil,Kim Tae Nam,Oh Cheol Kyu,Kim Soo Dong,Park Sung-Woo,Chung Jae Sung,Park Sang Hyun,Lee Wan,Sung Gyung Tak,Chung Moon Kee,Chung Jae Il

Funder

Pusan National University Hospital

Publisher

Korean Urological Oncology Society

Link

http://www.kjuo.or.kr/upload/pdf/kjuo-15-2-59.pdf

Reference29 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

2. The Change of Prostate Cancer Treatment in Korea: 5 Year Analysis of a Single Institution

3. Current Status of Endocrine Therapy for Prostate Cancer in Japan Analysis of Primary Androgen Deprivation Therapy on the Basis of Data Collected by J-CaP

4. Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question;Endocrine;2022-08-20

2. Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network;European Journal of Cancer;2021-09

3. Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy;The World Journal of Men's Health;2020